• Nano-X projected Q2 revenue of about $4.0 million-$4.1 million, up from $3 million a year earlier.
• Teleradiology revenue seen at about $2.9 million versus $2.7 million; imaging systems and OEM services about $0.2 million, flat year on year.
• AI and software revenue forecast at $1 million versus $0.1 million, mainly tied to consolidating Vaso Healthcare IT (Nanox Health IT).
• Cash, cash equivalents, short-term deposits, long-term restricted deposits expected at about $31.4 million at June 30 versus $60 million at Dec. 31.
• Management expects cash and deposits at June 30 will not fund operations for at least one year, raising substantial doubt about going concern.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nano-X Imaging Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-081025), on July 23, 2026, and is solely responsible for the information contained therein.